NORWALK LESLIE V sold 44.0% of their position (1.25K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $227.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/30/2026ACC: 0001533568-26-000012
Director
Since Sep 2019
-1.25K
Net shares
Net seller
$227.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
842.00 acquired · 2.09K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.25K
Price / share
$182.01
Trade value
$227.51K
% of position
44.0%
7/28/2026
2.84K→1.59K
Common Stock
Direct
Shares
+842.00
Price / share
$139.43
Trade value
$117.40K
% of position
53.0%
7/29/2026
1.59K→2.43K
Total
Net shares
−408.00
Net value
-$110.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/28/2026 | S · Sale | −1.25K | $182.01 | $227.51K | 44.0% | 2.84K | 1.59K |
| Common Stock Direct | 7/29/2026 | M · Option Exercise | +842.00 | $139.43 | $117.40K | 53.0% | 1.59K | 2.43K |
| Total | −408.00 | -$110.11K | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
842.00 shares
Shares
−842.00
Strike price
139.43
Held after
2.14K
Exercisable
—
7/29/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock842.00 shares | 7/29/2026 | M · Option Exercise | −842.00 | 139.43 | — | 2.14K |